Existing affordable drugs could rapidly reduce COVID-19 cases and deaths in India
Times of India - The COVID-19 humanitarian calamity unfolding in India is on a scale not seen in this pandemic. This is an extraordinary situation – and it may benefit from an extraordinary response.
There exist affordable, readily available and minimally toxic drugs approved for non-COVID-19 use which show remarkable promise in preventing or treating the new coronavirus. Deploying these drugs in India is likely to rapidly reduce the number of COVID-19 patients, reduce the number requiring hospitalization, supplemental oxygen and intensive care and improve outcomes in hospitalized patients.
|Credit: American Association of Physicians and Surgeons|
Vidula Sukhatme, MS, is an adjunct instructor at Emory University’s Rollins School of Public Health and is the founding CEO of GlobalCures, a non-profit that aims to promote promising therapies for cancer not being pursued for lack of profitability. Her contact is firstname.lastname@example.org